188 related articles for article (PubMed ID: 33336379)
1. Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.
Fleury E; Trnková P; Erdal E; Hassan M; Stoel B; Jaarma-Coes M; Luyten G; Herault J; Webb A; Beenakker JW; Pignol JP; Hoogeman M
Med Phys; 2021 Mar; 48(3):1315-1326. PubMed ID: 33336379
[TBL] [Abstract][Full Text] [Related]
2. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
3. Improving organs-at-risk sparing for choroidal melanoma patients: A CT-based two-beam strategy in ocular proton therapy with a dedicated eyeline.
Fleury E; Trnková P; van Rij C; Rodrigues M; Klaver Y; Spruijt K; Naus N; Zolnay A; Pignol JP; Kiliç E; Hoogeman MS
Radiother Oncol; 2022 Jun; 171():173-181. PubMed ID: 35487435
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
Hartsell WF; Kapur R; Hartsell SO; Sweeney P; Lopes C; Duggal A; Cohen J; Chang J; Polasani RS; Dunn M; Pankuch M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):353-359. PubMed ID: 27084652
[TBL] [Abstract][Full Text] [Related]
5. Automated Treatment Planning System for Uveal Melanomas Treated With Proton Therapy: A Proof-of-Concept Analysis.
Hennings F; Lomax A; Pica A; Weber DC; Hrbacek J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):724-731. PubMed ID: 29893280
[TBL] [Abstract][Full Text] [Related]
6. Technical note: Impact of beam properties for uveal melanoma proton therapy-An in silico planning study.
Wulff J; Koska B; Janson M; Bäumer C; Denker A; Geismar D; Gollrad J; Timmermann B; Heufelder J
Med Phys; 2022 May; 49(5):3481-3488. PubMed ID: 35218037
[TBL] [Abstract][Full Text] [Related]
7. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
8. Personalized Anatomic Eye Model From T1-Weighted Volume Interpolated Gradient Echo Magnetic Resonance Imaging of Patients With Uveal Melanoma.
Nguyen HG; Sznitman R; Maeder P; Schalenbourg A; Peroni M; Hrbacek J; Weber DC; Pica A; Bach Cuadra M
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):813-820. PubMed ID: 29970318
[TBL] [Abstract][Full Text] [Related]
9. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
[TBL] [Abstract][Full Text] [Related]
10. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
[TBL] [Abstract][Full Text] [Related]
11. Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Phys Med; 2018 Dec; 56():66-73. PubMed ID: 30527091
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional arterial spin labeling-guided dose painting radiotherapy for non-enhancing low-grade gliomas.
Zhu Z; Gong G; Wang L; Su Y; Lu J; Yin Y
Jpn J Radiol; 2023 Mar; 41(3):335-346. PubMed ID: 36342645
[TBL] [Abstract][Full Text] [Related]
15. 3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques.
Daftari Ik; Aghaian E; O'Brien JM; Dillon W; Phillips TL
Med Phys; 2005 Nov; 32(11):3355-62. PubMed ID: 16372413
[TBL] [Abstract][Full Text] [Related]
16. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
17. Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.
Gerard A; Peyrichon ML; Vidal M; Barnel C; Sauerwein W; Carnicer A; Angellier G; Mathis TM; Mishra KK; Thariat J; Herault J
Cancer Radiother; 2022 Nov; 26(8):1027-1033. PubMed ID: 35803862
[TBL] [Abstract][Full Text] [Related]
18. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
19. Treatment plan optimization and robustness of
Heilemann G; Fetty L; Dulovits M; Blaickner M; Nesvacil N; Georg D; Dunavoelgyi R
Radiother Oncol; 2017 Apr; 123(1):119-124. PubMed ID: 28185660
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
